An experimental treatment against ‘certain death’

Healthed

writer

Healthed

Healthed

It is risky and untested treatment. It could shorten his life or make it a whole lot worse. But it’s a risk Professor Richard Scolyer is willing to take, desperate to try and save his own life. As the world’s top melanoma pathologist, Richard is an expert in diagnosing skin cancers, and helped revolutionise immunotherapy treatment for advanced melanoma patients, removing the death sentence so many once faced. But now the acclaimed doctor is facing his own mortality. Richard had a choice, prepare for the worst or put his hand up to be patient zero as his colleagues design a high stakes experiment to fight his brain tumour, using the very treatment they have pioneered for melanoma.

 

 

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Belinda Welsh

Dr Belinda Welsh

Rosacea – Smarter Diagnosis and State-of-the-Art Care

A/Prof Ralph Audehm & Prof Genie Pedagogos

A/Prof Ralph Audehm & Prof Genie Pedagogos

The Role of SGLT2 Inhibitors in Preventing Dialysis

Prof Jason Ong

Prof Jason Ong

Syphilis is on the Rise – What GPs Can do to Turn it Around

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

COPD Cases

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Rosacea – Smarter diagnosis & state-of-the-art care

Tuesday 14th April, 7pm - 9pm AEST

Speaker

Dr Belinda Welsh

Dermatologist; Senior Vice President, Australasian Society of Cosmetic Dermatologists

Join Dr Belinda Welsh, who will also present a practical framework for the effective management of rosacea, a condition that can be controlled by not cured.